Cantor Fitzgerald Investment Advisors L.P. reduced its stake in MetLife, Inc. (NYSE:MET – Free Report) by 0.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 147,467 shares of the financial services provider’s stock after selling 774 shares during the quarter. Cantor Fitzgerald Investment Advisors L.P.’s holdings in MetLife were worth $11,859,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Kathmere Capital Management LLC raised its position in MetLife by 88.2% in the 2nd quarter. Kathmere Capital Management LLC now owns 6,328 shares of the financial services provider’s stock valued at $509,000 after buying an additional 2,965 shares during the last quarter. First Horizon Advisors Inc. grew its stake in shares of MetLife by 4.8% during the 1st quarter. First Horizon Advisors Inc. now owns 422,684 shares of the financial services provider’s stock worth $33,937,000 after acquiring an additional 19,192 shares in the last quarter. Ritholtz Wealth Management raised its holdings in shares of MetLife by 52.1% in the first quarter. Ritholtz Wealth Management now owns 9,355 shares of the financial services provider’s stock valued at $751,000 after purchasing an additional 3,204 shares during the last quarter. Pinnacle Financial Partners Inc bought a new stake in shares of MetLife in the first quarter worth $255,000. Finally, Mirae Asset Global Investments Co. Ltd. boosted its holdings in MetLife by 20.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 60,785 shares of the financial services provider’s stock worth $4,735,000 after purchasing an additional 10,414 shares during the last quarter. Institutional investors own 94.99% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on MET shares. Barclays lifted their price target on shares of MetLife from $88.00 to $94.00 and gave the company an “overweight” rating in a research note on Monday, July 7th. Keefe, Bruyette & Woods lowered their target price on MetLife from $94.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, August 11th. Wells Fargo & Company reissued an “overweight” rating and set a $97.00 price target (up from $94.00) on shares of MetLife in a research report on Thursday, July 10th. UBS Group lowered their price target on MetLife from $94.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday, August 7th. Finally, Cowen reissued a “buy” rating on shares of MetLife in a report on Friday, August 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.64.
MetLife Price Performance
NYSE:MET opened at $82.06 on Thursday. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The firm has a market capitalization of $54.57 billion, a price-to-earnings ratio of 13.91, a P/E/G ratio of 0.74 and a beta of 0.86. The stock’s 50 day moving average price is $78.96 and its two-hundred day moving average price is $78.20. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57.
MetLife (NYSE:MET – Get Free Report) last posted its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. During the same period in the previous year, the firm posted $2.28 earnings per share. The firm’s revenue was down 2.7% compared to the same quarter last year. On average, analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th were issued a dividend of $0.5675 per share. The ex-dividend date of this dividend was Tuesday, August 5th. This represents a $2.27 annualized dividend and a dividend yield of 2.8%. MetLife’s payout ratio is presently 38.47%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- The Role Economic Reports Play in a Successful Investment Strategy
- Datavault AI: The New AI Contender Backed by Big Funding
- Using the MarketBeat Stock Split Calculator
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- What is MarketRank� How to Use it
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.